These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 1533816

  • 1. Amplification and expression of the human cyclin D gene in esophageal cancer.
    Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH, Weinstein IB.
    Cancer Res; 1992 May 15; 52(10):2980-3. PubMed ID: 1533816
    [Abstract] [Full Text] [Related]

  • 2. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.
    Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM, Weinstein IB.
    Biochem Biophys Res Commun; 1993 Oct 29; 196(2):1010-6. PubMed ID: 8240318
    [Abstract] [Full Text] [Related]

  • 3. Amplification and overexpression of EXP1 and EXP2/Cyclin D1 genes in human esophageal carcinomas.
    Tsuruta H, Sakamoto H, Onda M, Terada M.
    Biochem Biophys Res Commun; 1993 Nov 15; 196(3):1529-36. PubMed ID: 8250909
    [Abstract] [Full Text] [Related]

  • 4. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
    Schuuring E, Verhoeven E, Mooi WJ, Michalides RJ.
    Oncogene; 1992 Feb 15; 7(2):355-61. PubMed ID: 1532244
    [Abstract] [Full Text] [Related]

  • 5. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas.
    Tsuda T, Tahara E, Kajiyama G, Sakamoto H, Terada M, Sugimura T.
    Cancer Res; 1989 Oct 15; 49(20):5505-8. PubMed ID: 2529025
    [Abstract] [Full Text] [Related]

  • 6. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
    Bringuier PP, Tamimi Y, Schuuring E, Schalken J.
    Oncogene; 1996 Apr 18; 12(8):1747-53. PubMed ID: 8622895
    [Abstract] [Full Text] [Related]

  • 7. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
    Jares P, Fernández PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A.
    Cancer Res; 1994 Sep 01; 54(17):4813-7. PubMed ID: 8062283
    [Abstract] [Full Text] [Related]

  • 8. [Loss of CDKN2 gene and amplification of cyclin D1 gene in human esophageal cancer].
    Zheng J, Hou P, Zhou C.
    Zhonghua Zhong Liu Za Zhi; 1996 Nov 01; 18(6):408-11. PubMed ID: 9387288
    [Abstract] [Full Text] [Related]

  • 9. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
    Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP.
    Cancer; 1997 Jan 15; 79(2):380-9. PubMed ID: 9010112
    [Abstract] [Full Text] [Related]

  • 10. [Analysis of the p16INK4, p15INK4B genes abnormality and the amplification of cyclin D1 gene in esophageal cancer].
    Takamura H, Fushida S, Hashimoto T, Yagi M, Miyazaki I.
    Nihon Rinsho; 1996 Apr 15; 54(4):1043-8. PubMed ID: 8920671
    [Abstract] [Full Text] [Related]

  • 11. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors.
    Yuan B, Oechsli MN, Hendler FJ.
    Oncogene; 1997 Sep 04; 15(10):1161-70. PubMed ID: 9294609
    [Abstract] [Full Text] [Related]

  • 12. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line.
    Lebwohl DE, Muise-Helmericks R, Sepp-Lorenzino L, Serve S, Timaul M, Bol R, Borgen P, Rosen N.
    Oncogene; 1994 Jul 04; 9(7):1925-9. PubMed ID: 8208539
    [Abstract] [Full Text] [Related]

  • 13. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer.
    Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T.
    Am J Pathol; 1995 May 04; 146(5):1161-9. PubMed ID: 7747810
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
    Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB.
    Oncogene; 1993 Dec 04; 8(12):3447-57. PubMed ID: 8247550
    [Abstract] [Full Text] [Related]

  • 15. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information.
    Shinozaki H, Ozawa S, Ando N, Tsuruta H, Terada M, Ueda M, Kitajima M.
    Clin Cancer Res; 1996 Jul 04; 2(7):1155-61. PubMed ID: 9816282
    [Abstract] [Full Text] [Related]

  • 16. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
    Huang L, Lang D, Geradts J, Obara T, Klein-Szanto AJ, Lynch HT, Ruggeri BA.
    Mol Carcinog; 1996 Feb 04; 15(2):85-95. PubMed ID: 8599583
    [Abstract] [Full Text] [Related]

  • 17. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma.
    Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, Amenomori M, Shibagaki I, Nakao K, Ikenaga M.
    Cancer Res; 1994 Jun 15; 54(12):3107-10. PubMed ID: 8205525
    [Abstract] [Full Text] [Related]

  • 18. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
    Shuster MI, Han L, Le Beau MM, Davis E, Sawicki M, Lese CM, Park NH, Colicelli J, Gollin SM.
    Genes Chromosomes Cancer; 2000 Jun 15; 28(2):153-63. PubMed ID: 10825000
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of cyclin D1 in mouse skin carcinogenesis.
    Bianchi AB, Fischer SM, Robles AI, Rinchik EM, Conti CJ.
    Oncogene; 1993 May 15; 8(5):1127-33. PubMed ID: 8479737
    [Abstract] [Full Text] [Related]

  • 20. Amplification of cyclin genes in colorectal carcinomas.
    Leach FS, Elledge SJ, Sherr CJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B.
    Cancer Res; 1993 May 01; 53(9):1986-9. PubMed ID: 8481900
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.